查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713580

2025年全球流動止血鉗市場報告

Flowable Hemostats Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年流動止血鉗市場規模將強勁成長。到 2029 年，這一數字將成長至 13.7 億美元，年複合成長率（CAGR）為 7.6%。預測期內的成長是由於外科手術數量的增加、慢性病盛行率的上升、對微創手術的需求不斷成長以及需要外科治療的老年人口的增加。預測期內的關鍵趨勢包括先進生物工程材料的整合、智慧止血材料的開發、機器人輔助和微創手術技術、採用針對患者和個人化的止血解決方案以及止血材料的高級客製化。

流動止血鉗市場的成長是由外科手術數量的增加所推動的。這種成長是由於人口老化增加了與老齡化相關的手術的需求，以及技術進步使得手術更安全、更容易獲得。流動止血鉗在外科手術中特別有用，可以控制難以觸及的區域或傳統方法無效的出血。例如，美國專業非政府組織國際美容整形外科學會（ISAPS）2024年6月的報告顯示，2023年全球手術和非手術整形總數與前一年同期比較去年同期成長3.4%，達到3,490萬例。因此，手術數量的增加促進了流動止血材料市場的擴大。

流動止血劑市場的主要企業正致力於開發無膨脹技術等先進止血劑，以滿足外科手術不斷變化的需求。 No-Swell 技術是一種在吸收液體時不會膨脹的止血劑，使其成為腫脹可能導致併發症的手術的理想選擇。例如，2023年1月，美國外科技術公司Medcura Inc.憑藉其LifeGel流體技術獲得FDA突破性醫療設備稱號。 LifeGel 旨在控制手術期間無法忍受腫脹的出血。它是第一種也是唯一一種專門解決止血腫脹相關問題的流動止血凝膠。這種可吸收藥物可保持水分而不會腫脹，可隨時使用，可能降低神經損傷和癱瘓的風險。它具有成本效益、抗菌、相對透明且黏附於組織的特點，為複雜手術過程中的出血控制提供了更安全、更有效的解決方案。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球流動性靜態材料PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球流動止血鉗市場：成長率分析
  • 全球流動止血鉗市場表現：規模與成長，2019-2024 年
  • 全球流動止血鉗市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球液體止血劑總目標市場（TAM）

第6章市場區隔

  • 全球流動止血鉗市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 主動止血劑
  • 被動止血劑
  • 複合止血鉗
  • 全球流動止血鉗市場：按材料、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 豬肉明膠
  • 牛明膠
  • 全球流動止血鉗市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 一般外科
  • 心血管手術
  • 血管外科
  • 神經脊椎手術
  • 整形外科
  • 其他用途
  • 全球流動止血鉗市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 門診手術中心
  • 全球流動止血鉗市場，依主動止血鉗類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 纖維蛋白膠
  • 凝血酶類止血劑
  • 膠原蛋白基止血劑
  • 生物分解性生物分解高分子止血材料
  • 全球流動止血劑市場細分（依被動止血劑類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 紗布止血鉗
  • 海綿和墊片
  • 纖維素止血材料
  • 顆粒止血劑
  • 全球流動止血劑市場複合止血劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 纖維蛋白原和凝血酶組合產品
  • 膠原蛋白和纖維蛋白組合產品
  • 合成複方止血劑
  • 生物可吸收複合止血材料

第7章 區域和國家分析

  • 全球流動止血鉗市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球流動止血鉗市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 液體止血劑市場：競爭格局
  • 流動止血鉗市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Baxter International Inc.
  • B Braun Melsungen AG
  • Becton Dickinson and Company
  • Cook Medical Inc.
  • Teleflex Incorporated
  • Mallinckrodt Pharmaceuticals
  • Integra LifeSciences Holdings Corporation
  • Gelita Medical GmbH
  • Ferrosan Medical Devices A/S
  • Marine Polymer Technologies Inc
  • Axio Biosolutions Private Limited
  • Hemostasis LLC
  • Aegis Lifesciences Private Limited
  • Medcura Health Inc
  • Arch Therapeutics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年流動止血鉗市場：提供新機會的國家
  • 2029 年流動止血鉗市場：細分市場帶來新機會
  • 2029 年流動止血鉗市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33482

Flowable hemostats are gelatinous medical devices designed to control bleeding during surgery by adapting to irregular wound shapes for effective application. They aid clotting by creating a physical barrier and activating the body's coagulation cascade, making them suitable for use in complex or delicate surgical areas.

The main types of flowable hemostats are active hemostats, passive hemostats, and combination hemostats. Active hemostats are specialized medical agents that actively contribute to the blood clotting process, enhancing hemostasis during surgeries or in bleeding situations. They can be made from materials such as porcine gelatin and bovine gelatin and are used in various surgical fields, including general, cardiac, vascular, neuro and spine, and orthopedic surgeries. These hemostats are designed to meet the needs of different end users, including hospitals, clinics, and ambulatory surgery centers.

The flowable hemostats market research report is one of a series of new reports from The Business Research Company that provides flowable hemostats market statistics, including flowable hemostats industry global market size, regional shares, competitors with a flowable hemostats market share, detailed flowable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the flowable hemostats industry. This flowable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The flowable hemostats market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth in elective surgeries, rising adoption of personalized medicine, increased healthcare spending, and expansion of healthcare infrastructure in emerging markets.

The flowable hemostats market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the increasing number of surgical procedures, rising prevalence of chronic diseases, growing demand for minimally invasive surgeries, and an expanding geriatric population requiring surgical care. Major trends in the forecast period include integration of advanced bioengineered materials, development of smart hemostatic products, robotic-assisted and minimally invasive surgical techniques, adoption of patient-specific and personalized hemostatic solutions, and advanced customization of hemostats.

The growth of the flowable hemostats market is expected to be driven by the rising number of surgical procedures. This increase is attributed to an aging population, which creates a higher demand for age-related surgeries, as well as technological advancements that have made surgeries safer and more accessible. Flowable hemostats are particularly valuable in surgical procedures for controlling bleeding in hard-to-reach areas or where traditional methods might be ineffective. For example, in June 2024, a report by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, revealed that the total number of surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million compared to the previous year. Thus, the growing number of surgical procedures is contributing to the expansion of the flowable hemostats market.

Major companies in the flowable hemostats market are concentrating on developing advanced hemostatic agents, such as no-swell technology, to meet the evolving needs of surgical procedures. No-swell technology describes a hemostatic agent that does not absorb fluids and expand, making it suitable for surgeries where swelling could lead to complications. For example, in January 2023, Medcura Inc., a US-based surgical technology company, received FDA breakthrough device designation for its LifeGel flowable technology. LifeGel is designed to control bleeding during surgeries where swelling is not acceptable. It is the first and only flowable hemostatic gel specifically addressing issues related to hemostatic swelling. The absorbable agent remains hydrated and ready-to-use without swelling, potentially reducing risks such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, is relatively transparent, and adheres to tissues, offering a safer and more effective solution for managing bleeding in complex surgical procedures.

In May 2022, Ethicon, a company based in the United States that specializes in surgical technologies, purchased GATT Technologies B.V. for an undisclosed sum. The goal of this acquisition was to strengthen Ethicon's portfolio of hemostatic and sealant solutions by incorporating GATT Technologies' advanced products to enhance surgical results. GATT Technologies B.V., located in the Netherlands, is recognized for its innovative advancements in hemostatic and sealant products used in medical applications.

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the flowable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The flowable hemostats market consists of sales of synthetic flowable hemostats, fibrin sealant-based hemostats, and collagen-based flowable hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flowable Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flowable hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flowable hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flowable hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats
  • 2) By Material: Porcine Gelatin; Bovine Gelatin
  • 3) By Application: General Surgery; Cardiac Surgery; Vascular Surgery; Neuro And Spine Surgery; Orthopedic Surgery; Other Applications
  • 4) By End User: Hospital And Clinics; Ambulatory Surgery Centers
  • Subsegments:
  • 1) By Active Hemostats: Fibrin Sealants; Thrombin-Based Hemostats; Collagen-Based Hemostats; Biodegradable Polymer Hemostats
  • 2) By Passive Hemostats: Gauze-Based Hemostats; Sponges and Pads; Cellulose-Based Hemostats; Granule-Based Hemostats
  • 3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products; Collagen and Fibrin Combination Products; Synthetic Combination Hemostats; Bioresorbable Combination Hemostats
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medtronic plc; Medline Industries Inc.; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flowable Hemostats Market Characteristics

3. Flowable Hemostats Market Trends And Strategies

4. Flowable Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Flowable Hemostats Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Flowable Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Flowable Hemostats Market Growth Rate Analysis
  • 5.4. Global Flowable Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Flowable Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Flowable Hemostats Total Addressable Market (TAM)

6. Flowable Hemostats Market Segmentation

  • 6.1. Global Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • 6.2. Global Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porcine Gelatin
  • Bovine Gelatin
  • 6.3. Global Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • General Surgery
  • Cardiac Surgery
  • Vascular Surgery
  • Neuro And Spine Surgery
  • Orthopedic Surgery
  • Other Applications
  • 6.4. Global Flowable Hemostats Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinics
  • Ambulatory Surgery Centers
  • 6.5. Global Flowable Hemostats Market, Sub-Segmentation Of Active Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fibrin Sealants
  • Thrombin-Based Hemostats
  • Collagen-Based Hemostats
  • Biodegradable Polymer Hemostats
  • 6.6. Global Flowable Hemostats Market, Sub-Segmentation Of Passive Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gauze-Based Hemostats
  • Sponges and Pads
  • Cellulose-Based Hemostats
  • Granule-Based Hemostats
  • 6.7. Global Flowable Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fibrinogen and Thrombin Combination Products
  • Collagen and Fibrin Combination Products
  • Synthetic Combination Hemostats
  • Bioresorbable Combination Hemostats

7. Flowable Hemostats Market Regional And Country Analysis

  • 7.1. Global Flowable Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Flowable Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Flowable Hemostats Market

  • 8.1. Asia-Pacific Flowable Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Flowable Hemostats Market

  • 9.1. China Flowable Hemostats Market Overview
  • 9.2. China Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Flowable Hemostats Market

  • 10.1. India Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Flowable Hemostats Market

  • 11.1. Japan Flowable Hemostats Market Overview
  • 11.2. Japan Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Flowable Hemostats Market

  • 12.1. Australia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Flowable Hemostats Market

  • 13.1. Indonesia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Flowable Hemostats Market

  • 14.1. South Korea Flowable Hemostats Market Overview
  • 14.2. South Korea Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Flowable Hemostats Market

  • 15.1. Western Europe Flowable Hemostats Market Overview
  • 15.2. Western Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Flowable Hemostats Market

  • 16.1. UK Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Flowable Hemostats Market

  • 17.1. Germany Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Flowable Hemostats Market

  • 18.1. France Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Flowable Hemostats Market

  • 19.1. Italy Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Flowable Hemostats Market

  • 20.1. Spain Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Flowable Hemostats Market

  • 21.1. Eastern Europe Flowable Hemostats Market Overview
  • 21.2. Eastern Europe Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Flowable Hemostats Market

  • 22.1. Russia Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Flowable Hemostats Market

  • 23.1. North America Flowable Hemostats Market Overview
  • 23.2. North America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Flowable Hemostats Market

  • 24.1. USA Flowable Hemostats Market Overview
  • 24.2. USA Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Flowable Hemostats Market

  • 25.1. Canada Flowable Hemostats Market Overview
  • 25.2. Canada Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Flowable Hemostats Market

  • 26.1. South America Flowable Hemostats Market Overview
  • 26.2. South America Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Flowable Hemostats Market

  • 27.1. Brazil Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Flowable Hemostats Market

  • 28.1. Middle East Flowable Hemostats Market Overview
  • 28.2. Middle East Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Flowable Hemostats Market

  • 29.1. Africa Flowable Hemostats Market Overview
  • 29.2. Africa Flowable Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Flowable Hemostats Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Flowable Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Flowable Hemostats Market Competitive Landscape And Company Profiles

  • 30.1. Flowable Hemostats Market Competitive Landscape
  • 30.2. Flowable Hemostats Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Flowable Hemostats Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. B Braun Melsungen AG
  • 31.3. Becton Dickinson and Company
  • 31.4. Cook Medical Inc.
  • 31.5. Teleflex Incorporated
  • 31.6. Mallinckrodt Pharmaceuticals
  • 31.7. Integra LifeSciences Holdings Corporation
  • 31.8. Gelita Medical GmbH
  • 31.9. Ferrosan Medical Devices A/S
  • 31.10. Marine Polymer Technologies Inc
  • 31.11. Axio Biosolutions Private Limited
  • 31.12. Hemostasis LLC
  • 31.13. Aegis Lifesciences Private Limited
  • 31.14. Medcura Health Inc
  • 31.15. Arch Therapeutics Inc.

32. Global Flowable Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Flowable Hemostats Market

34. Recent Developments In The Flowable Hemostats Market

35. Flowable Hemostats Market High Potential Countries, Segments and Strategies

  • 35.1 Flowable Hemostats Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Flowable Hemostats Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Flowable Hemostats Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33482_Flowable_Hemostats_GMR_2025